Afatinib Dimaleate
| CAS No. | 850140-73-7 |
|---|---|
| MDL No. | MFCD25974239 |
| MF | C32H33ClFN5O11 |
| MW | 718.10 |
| InChI Key | USNRYVNRPYXCSP-JUGPPOIOSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Afatinib dimaleate is a maleate salt formed by combining afatinib with two molar equivalents of maleic acid. It is used as a first-line treatment for metastatic non-small cell lung cancer. It functions as a tyrosine kinase inhibitor and antineoplastic agent, containing afatinib.
| CAS No. | 850140-73-7 |
|---|---|
| Product Name | Afatinib Dimaleate |
Biological Targets
EGFR·ERBB2·ERBB4
Associated Conditions
non-small cell lung carcinoma·multiple myeloma
* The information provided here is compiled from public sources and is for reference only.
